Related Experiment Video

Updated: Jun 6, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus

Xiaoke Wu1, Shaokuan Fang1

  • 1Department of Neurology, Neuroscience Centre, The First Hospital of Jilin University, Changchun, China.

Frontiers in Immunology
|November 26, 2024
PubMed

Insights

Oncolytic virus therapy (OVT) uses viruses to target and destroy cancer cells while stimulating the immune system. Understanding OVT

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Oncolytic viruses are natural or engineered viruses.
  • They selectively replicate in and destroy cancer cells.
  • Oncolytic virus therapy (OVT) is an emerging cancer treatment.

Purpose of the Study:

  • To review the properties of oncolytic viruses.
  • To overview immune cells and the tumor microenvironment (TME) in OVT.
  • To identify novel therapeutic targets for cancer treatment.

Main Methods:

  • Literature review of oncolytic virus properties.
  • Analysis of immune cell roles in OVT.
  • Examination of tumor microenvironment interactions in OVT.

Main Results:

  • Oncolytic viruses activate immune cells.
  • Selective replication in cancer cells without harming healthy tissue.
  • Understanding OVT immunology is key.

Conclusions:

  • Oncolytic viruses offer a promising cancer treatment strategy.
  • Further understanding of OVT immunological mechanisms is crucial.
  • This knowledge can lead to improved cancer therapies.
Keywords:
immune celloncolytic virustreatmenttumortumor microenvironment

More Related Videos

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.5K
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

855

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
751
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.5K